SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

LUPIN

BSE: 500257 02 Jul 2025
Healthcare
₹ 1936.5
Lupin Ltd specializes in Pharmaceuticals within the Healthcare sector.

LUPIN - Share Price & Details

Market Cap
₹87,774
High /Low
2,403 / 1,615
Stock P/E
26.7
Book Value
₹377.0
Dividend Yield
0.41
ROCE
21.5
ROE
₹20.8
Face Value
2.0
PEG Ratio
0.49
EVEBITDA
₹16.4
Debt
5,448
CMP / FCF
58.3
Debt to equity
₹0.32
NP Ann
3,306
High price all time
2,403
Piotroski score
₹6.0
Graham Number
781.0
No. Eq. Shares
45.7
Net CF
₹560
Net profit
3,306
Price to book value
5.14
Interest Coverage
₹14.6
Low price all time
52.5
Industry PE
33.3
Reserves
₹17,112
Free Cash Flow
₹1,347

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.02251.0
Triochem Products Ltd.,NANANANA0
LUPIN LTD.45344.612913.544856.728.2187,77426.7
ABBOTT INDIA LTD.NANANANA7401752.3
AUROBINDO PHARMA LTD.NANANANA6634019.0

Peer Comparison Chart


About LUPIN

Lupin Ltd, with Security Code 500257, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Lupin update on transfer of its OTC biz to LUPINLIFE Consumer Healthcare

(30 Jun 2025)
In terms of the BTA, the said transaction has been completed, and transfer of OTC Business will be effective from 01 July 2025.
Read more →

Pharmaceutical Industry is Set to Benefit from $63.7 Billion U.S. Patent Expiry Wave

(30 Jun 2025)
Indian pharma set to gain from $63.7B U.S. patent expiries, tapping LoE wave with complex generics and rising global opportunities.
Read more →

Lupin Ltd. Sees Significant Rise in Open Interest Amid Active Market Participation

(27 Jun 2025)
Lupin Ltd. has seen a notable rise in open interest, reaching 43,318 contracts, alongside a trading volume of 11,558 contracts, indicating active market...
Read more →

Lupin launches generic chronic constipation treatment drug in US

(27 Jun 2025)
NEW DELHI, June 26: Pharma major Lupin Ltd on Thursday said it has launched its generic version of Prucalopride tablets used to treat...
Read more →

Lupin gets US FDA nod for chronic constipation drug

(27 Jun 2025)
Posted inPharma. Lupin gets US FDA nod for chronic constipation drug. Lupin's goa facility to produce FDA-approved generic Prucalopride of...
Read more →

Lupin gets USFDA nod for new constipation drug, stock gains

(26 Jun 2025)
This product, bioequivalent to Motegrity Tablets of Takeda Pharmaceuticals, will be manufactured at Lupin's Goa facility in India.
Read more →

Company Updates